Skip to main content

Table 1 PCA/multivariate Analysis models for plasma

From: Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy

 

Model

# of Compounds

Total # Samples

# of Components

R2X

R2Y

Q2

# Samples in STZ

# Samples in NaC

Positive

PCA All Samples

2414

62

7

0.947

 

0.85

  

PCA 4 wks

2414

28

7

0.96

 

0.841

  

PCA WT STZ v WT NaC 4 wk

2414

14

4

0.937

 

0.759

  

OPLSDA WT STZ v WT NaC 4 wk

2414

14

1 + 1

0.75

0.619

0.0699

9

5

PCA βKO STZ v βKO NaC 4wk

2414

14

4

0.93

 

0.756

  

OPLSDA βKO STZ v βKO NaC 4wk

2414

14

1 + 3

0.908

0.956

0.788

8

6

PCA 8 wks

2414

28

5

0.942

 

0.834

  

PCA WT STZ v WT NaC 8 wk

2414

13

5

0.967

 

0.829

  

OPLSDA WT STZ v WT NaC 8 wk

2414

13

1 + 2

0.845

0.912

0.764

8

5

PCA βKO STZ v βKO NaC 8wk

2414

14

4

0.962

 

0.912

  

OPLSDA βKO STZ v βKO NaC 8wk

2414

14

1 + 7

0.984

1

0.731

8

6

Negative

PCA All Samples

633

57

8

0.877

 

0.711

  

PCA 4 wks

633

25

3

0.76

 

0.385

  

PCA WT STZ v WT NaC 4 wk

633

12

4

0.925

 

0.558

  

OPLSDA WT STZ v WT NaC 4 wk

633

12

1 + 2

0.873

0.962

0.876

7

5

PCA βKO STZ v βKO NaC 4wk

633

13

2

0.58

 

0.23

  

OPLSDA βKO STZ v βKO NaC 4wk

633

13

1 + 1

0.528

0.958

0.876

7

6

PCA 8 wk

633

26

3

0.759

 

0.478

  

PCA WT STZ v WT NaC 8 wk

633

12

3

0.866

 

0.497

  

OPLSDA WT STZ v WT NaC 8 wk

633

12

1 + 2

0.861

0.973

0.907

7

5

PCA βKO STZ v βKO NaC 8wk

633

14

3

0.759

 

0.174

  

OPLSDA βKO STZ v βKO NaC 8wk

633

14

1 + 1

0.498

0.871

0.686

8

6